PRODUCTS

Xencor is advancing into the clinic several proprietary XmAb^® antibodies for the treatment of cancer, autoimmune disease and inflammation. We exploit the bioactivity of our unique portfolio of XmAb^® engineered Fc domains to create highly selective immune-modulators for our autoimmune candidates and targeted, highly cytotoxic cancer therapies. We manage the risk inherent in the development of drugs by addressing primarily biologically validated targets and by applying the unique capability of our PDA^® technology platform to design next-generation antibody and protein therapeutics. The creation of a broad product portfolio increases opportunities for success and for partnering with pharmaceutical companies.